# Vaccine Plus Booster Shots in Men With Prostate Cancer Undergoing Treatment With Radical Prostatectomy

> **NCT02153918** · PHASE2 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 27 (actual)

## Conditions studied

- Prostate Cancer
- Prostatic Neoplasms
- Neoplasms, Prostate

## Interventions

- **BIOLOGICAL:** PROSTVAC-V/TRICOM
- **BIOLOGICAL:** PROSTVAC-F/TRICOM

## Key facts

- **NCT ID:** NCT02153918
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-05-31
- **Primary completion:** 2017-07-28
- **Final completion:** 2018-01-16
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2018-10-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02153918

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02153918, "Vaccine Plus Booster Shots in Men With Prostate Cancer Undergoing Treatment With Radical Prostatectomy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02153918. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*